Clinical Trials Directory

Trials / Unknown

UnknownNCT04191252

Genetic Mutation in Epithelial Ovarian Cancer

Overall Perspective on the Characteristics of Genetic Mutation in Chinese Patients of Epithelial Ovarian Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Lei Li · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Little is known about the characteristics of genetic mutation in a large multi-gene panel in epithelial ovarian cancer. This study is to explore the targeted genetic mutations via a multi-gene panel, which consists of more than 500 hundred genes. The mutation characteristics are to be revealed in single nucleotide variants, copy number variations, insertion-deletion variations, and genomic structural variations. The total mutation burden (TMB) will be calculated. The status of microsatellite instability, expression of PD-1 and PD-L1 antibodies are also tested. These findings will be studies in association with the patients' prognosis and sensitivity to platinum-based chemotherapy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTA multi-gene panel testingA multi-gene panel, which consists of more than 500 hundred genes will be provided for mutation analysis

Timeline

Start date
2019-12-19
Primary completion
2022-01-01
Completion
2023-01-01
First posted
2019-12-09
Last updated
2019-12-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04191252. Inclusion in this directory is not an endorsement.